You just read:

Entest BioMedical Inc.'s Subsidiary Zander Therapeutics Makes Key Additions to Management Team as the Company Prepares to Move Forward in the $63 Billion Veterinary / Pet Market Niche

News provided by

Entest BioMedical Inc.

06 Feb, 2017, 08:30 ET